List view / Grid view
28 January 2015 | By GlobalData
The acromegaly and gigantism treatment market will expand at a modest Compound Annual Growth Rate (CAGR) of 3.74% from approximately $588 million in 2013 to $707 million by 2018, limited by a sparse pipeline, according to research and consulting firm GlobalData...
Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the fourth quarter and full year of 2014, which were highlighted by strong global sales for priority brands and important advances in the company’s immuno-oncology (I-O) portfolio.
28 January 2015 | By Andrew Lloyd & Associates
ProveDye is a new sterile solution of methylene blue designed to aid visualization in surgical procedures. With ProveDye, Provepharm extends the Proveblue® methylene blue compound product range...
27 January 2015 | By Frost & Sullivan
Country-specific EHR implementation strategies will expedite market development, says Frost & Sullivan...
27 January 2015 | By Actavis
Actavis plc and the owners of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK, announced that they have reached a definitive agreement, under which Actavis will acquire Auden Mckenzie for approximately…
27 January 2015 | By Lukats and Shapiro
Half of UK bosses tempted to snoop on employees health app data to catch them ‘pulling a sickie’...
27 January 2015 | By Health Consumer Powerhouse
In spite of financial crisis, European healthcare keeps improving – but the equity gap widens...
27 January 2015 | By Moberg Pharma
Moberg Pharma AB announced that its partner, Menarini Asia-Pacific, has received approval for Moberg’s fungal nail product in China...
26 January 2015 | By Pegasus
Research shows 87% of users prefer Cetraben® Ointment compared with other widely prescribed ointments...
26 January 2015 | By IONICON
A fast GC add-on for PTR-TOFMS trace gas analyzers and the new PTR-QiTOF are now available...
26 January 2015 | By Lukats and Shapiro
Doctors fear the wealth of health data from the internet and smartphones could be creating a new army of “worried well”, a survey for the Astellas Innovation DebateTM shows...
26 January 2015 | By NewCap.
Santen SAS announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the granting of a marketing authorization for Ikervis®...
26 January 2015 | By Alliance Pharma plc
Alliance Pharma plc has appointed Nigel Clifford as an independent Non-Executive Director of the Company. Nigel will join the Board with immediate effect.
23 January 2015 | By Novartis
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Jakavi® (ruxolitinib) for the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea...
23 January 2015 | By GlaxoSmithKline
GSK has announced that the first batch of its candidate Ebola vaccine is being shipped to west Africa...
